Masters Pharmaceutical, Inc. Sustainability Profile
Masters Pharmaceutical, Inc., commonly referred to as MastersRx, is a leading player in the pharmaceutical industry, headquartered in the United States. Founded in 2003, the company has established a strong presence in key operational regions across North America, focusing on the development and distribution of high-quality pharmaceutical products. Specialising in generic and specialty medications, MastersRx is recognised for its commitment to innovation and quality assurance. The company’s core offerings include a diverse range of prescription medications that cater to various therapeutic areas, setting them apart through rigorous testing and compliance with industry standards. With a reputation for reliability and excellence, Masters Pharmaceutical has achieved significant milestones, positioning itself as a trusted partner in healthcare. Their dedication to improving patient outcomes and enhancing access to essential medications underscores their notable achievements in the competitive pharmaceutical landscape.
DitchCarbon Score
How does Masters Pharmaceutical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Masters Pharmaceutical, Inc.'s score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Masters Pharmaceutical, Inc.'s reported carbon emissions
Masters Pharmaceutical, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Masters Pharmaceutical may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. In the broader context of the pharmaceutical industry, many companies are increasingly adopting science-based targets and sustainability practices to mitigate climate impact. However, without specific emissions data or commitments from Masters Pharmaceutical, it is unclear how the company aligns with these industry trends.
How Carbon Intensive is Masters Pharmaceutical, Inc.'s Industry?
How Carbon Intensive is Masters Pharmaceutical, Inc.'s Location?
Masters Pharmaceutical, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Masters Pharmaceutical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
